3/31/2021

Pure MHC, LLC Announces Launch of Contract Research Service Division and Initial Collaboration Project with argenx

3/24/2021

Pure Transplant Solutions Announces Collaboration with Innobiochips to Develop Personalized Diagnostics for Post-Transplant Monitoring and Early Detection of Transplant Rejection

3/17/2021

Pure Transplant Solutions Announces Collaboration with Northwestern University to Develop Novel Reagents for Enhanced Characterization of HLA DQ Antigens In Transplant Rejection

3/16/2021

Pure MHC, LLC Announces Launch of its Peptide HLA Immunotherapy Data Resource following Collaboration with LifeNet Health

3/11/2021

Pure Transplant Solutions Announces Collaboration with the University of Alabama at Birmingham to Develop Memory B Cell-Directed Diagnostics for HLA-Sensitized Patients

2/24/2021

Pure Transplant Solutions Announces Collaboration with King’s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease

2/23/2021

Caisson Biotech, LLC & Heparinex, LLC Announce Positive Examination Report of European Patent and the Discovery of a New Class of Sugar Polymers

2/04/2021

Pure Protein, LLC and Pure Transplant Solutions, LLC Promote Blake Harlan to President and Dr. Rico Buchli to Vice President of Products and Service

1/27/2021

Pure Transplant Solutions, LLC and University Hospital Basel Announce Research Collaboration

11/30/2020

Pure Protein, LLC Announces New Website Launch Now Offering Its HLA Reagents and Technical Services to Researchers

3/20/2020

OU Health Sciences Center Partners With Pure MHC on COVID-19 Vaccine Project